New Financing Supports Bifurcation Stent Company’s Expansion

October 14, 2010 – A bifurcation stent maker has closed $17 million in round D financing to help it expand worldwide, pursue research and development and seek out regulatory approvals in the United States, Japan and China. TriReme Medical announced the funding, which was led by Bio*One Capital.

The company’s Antares Coronary Stent System received CE mark for European sales in 2008. Antares is a thin strut (0.0035 inch) stainless steel stent with progressive surface finish. It permits deployment at or near bifurcation lesions with a single balloon inflation and maintains access to the side branch throughout the procedure, so recrossing with another wire is not required.